Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer

NCT00407563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Cancer
Primary Peritoneal Carcinoma

Interventions

DRUG: Bevacizumab
DRUG: Abraxane

Sponsor

Accelerated Community Oncology Research Network

Collaborators

[object Object]
[object Object]